Company page

Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc. (ticker: ATXI) is a public company based in the United States with a market capitalization of approximately $988,490. The company focuses on developing and commercializing innovative therapies for patients. Avenue Therapeutics is committed to advancing its pipeline to address unmet medical needs.